Veterinary Medicines

Continence 40 mg/ml Syrup for Dogs

Authorised
  • Phenylpropanolamine hydrochloride
Download as PDF

Product identification

Medicine name:
CONTINENCE 40 mg/ml syrup for dogs
Continence 40 mg/ml Syrup for Dogs
Active substance:
  • Phenylpropanolamine hydrochloride
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Phenylpropanolamine hydrochloride
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Syrup
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG04BX91
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Available in:
  • United Kingdom (Northern Ireland)
Package description:
  • 50 ml high-density polyethylene (HDPE) bottle with a low-density polyethylene (LDPE) dosing syringe adaptor and a child-resistant screw-cap in polypropylene and polyethylene. The cardboard box contains 1.5 ml LDPE/polystyrene dosing syringe.
  • 100 ml high-density polyethylene (HDPE) bottle with a low-density polyethylene (LDPE) dosing syringe adaptor and a child-resistant screw-cap in polypropylene and polyethylene. The cardboard box contains 1.5 ml LDPE/polystyrene dosing syringe.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 11557/4004
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0446/001
Concerned member states:
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."